Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Logan Meurer's research centers on the management of local anesthetic systemic toxicity (LAST), with a specific focus on the use of intravenous lipid emulsions as an antidote. Meurer has investigated the potential complications associated with this treatment, including an instance where the antidote may have exacerbated the patient's condition. This led to the study of emergent therapeutic plasma exchange as a subsequent intervention. Collaborating with Gina Drobena, P Ravikumar, and Brooke Yasgur at the University of Arkansas for Medical Sciences, Meurer's work contributes to understanding critical care interventions for LAST.
Metrics
- h-index: 1
- Publications: 1
- Citations: 3
Selected Publications
-
New-Onset Sarcoidosis During B-cell Maturation Antigen (BCMA)-Directed T-cell Engager Therapy With Teclistamab in Relapsed/Refractory High-Risk Multiple Myeloma: A Case Report and Mechanistic Insight (2026)
-
Antidote Worse Than the Poison? Emergent Therapeutic Plasma Exchange After Overzealous Intravenous Lipid Emulsion Infusion During Treatment of Local Anesthetic Systemic Toxicity (2025)
Collaboration Network
Top Collaborators
- Antidote Worse Than the Poison? Emergent Therapeutic Plasma Exchange After Overzealous Intravenous Lipid Emulsion Infusion During Treatment of Local Anesthetic Systemic Toxicity
- Antidote Worse Than the Poison? Emergent Therapeutic Plasma Exchange After Overzealous Intravenous Lipid Emulsion Infusion During Treatment of Local Anesthetic Systemic Toxicity
- Antidote Worse Than the Poison? Emergent Therapeutic Plasma Exchange After Overzealous Intravenous Lipid Emulsion Infusion During Treatment of Local Anesthetic Systemic Toxicity
- Antidote Worse Than the Poison? Emergent Therapeutic Plasma Exchange After Overzealous Intravenous Lipid Emulsion Infusion During Treatment of Local Anesthetic Systemic Toxicity
Similar Researchers
Based on overlapping research topics